Researchers sought to evaluate the relationship among insomnia symptoms, inflammation, and risk for stroke.
Your search for major depressive disorder returned 2 results
Click on a filter below to refine your search. Remove a filter to broaden your search.
Solanezumab is a humanized monoclonal antibody designed to increase clearance of soluble amyloid beta (Aβ) from the brain by binding to aggregated forms of Aβ.
Latest News Your top articles for TuesdayFor More Personalized News
Haymarket Medical NetworkTop Picks
Continuing Medical Education (CME/CE) Courses